DK163209C - To- eller tretrinskombinationspraeparat til oral kontraception - Google Patents

To- eller tretrinskombinationspraeparat til oral kontraception

Info

Publication number
DK163209C
DK163209C DK623684A DK623684A DK163209C DK 163209 C DK163209 C DK 163209C DK 623684 A DK623684 A DK 623684A DK 623684 A DK623684 A DK 623684A DK 163209 C DK163209 C DK 163209C
Authority
DK
Denmark
Prior art keywords
oral
contraction
combination preparations
step combination
preparations
Prior art date
Application number
DK623684A
Other languages
Danish (da)
English (en)
Other versions
DK623684A (da
DK163209B (da
DK623684D0 (da
Inventor
Ursula Lachnit-Fixson
Renate Unger
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK623684D0 publication Critical patent/DK623684D0/da
Publication of DK623684A publication Critical patent/DK623684A/da
Publication of DK163209B publication Critical patent/DK163209B/da
Application granted granted Critical
Publication of DK163209C publication Critical patent/DK163209C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK623684A 1983-12-22 1984-12-21 To- eller tretrinskombinationspraeparat til oral kontraception DK163209C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3347125 1983-12-22
DE19833347125 DE3347125A1 (de) 1983-12-22 1983-12-22 Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption

Publications (4)

Publication Number Publication Date
DK623684D0 DK623684D0 (da) 1984-12-21
DK623684A DK623684A (da) 1985-06-23
DK163209B DK163209B (da) 1992-02-10
DK163209C true DK163209C (da) 1992-06-29

Family

ID=6218183

Family Applications (1)

Application Number Title Priority Date Filing Date
DK623684A DK163209C (da) 1983-12-22 1984-12-21 To- eller tretrinskombinationspraeparat til oral kontraception

Country Status (18)

Country Link
US (1) US4621079A (el)
EP (1) EP0148724B1 (el)
JP (1) JPS60169419A (el)
AT (1) ATE34665T1 (el)
AU (1) AU560487B2 (el)
CA (1) CA1252047A (el)
CY (1) CY1464A (el)
DE (2) DE3347125A1 (el)
DK (1) DK163209C (el)
FI (1) FI83288C (el)
HK (1) HK12289A (el)
IL (1) IL73889A (el)
MY (1) MY101778A (el)
NO (1) NO166756C (el)
NZ (1) NZ210626A (el)
PH (1) PH23373A (el)
SG (1) SG72588G (el)
ZA (1) ZA8410015B (el)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4921843A (en) * 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
USRE35724E (en) * 1982-04-28 1998-02-03 Bio-Technology General Corp. Contraception system and method
US4762717A (en) * 1986-03-21 1988-08-09 The General Hospital Corporation Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive
DK174724B1 (da) * 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
GB2217988B (en) * 1988-04-11 1992-04-01 Gould Leonard W Regimen for increasing bone density in humans
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US5747480A (en) * 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive
US5858405A (en) * 1996-07-26 1999-01-12 American Home Products Corporation Oral contraceptive
US6451778B1 (en) 1996-07-26 2002-09-17 Wyeth Oral contraceptive
US6479475B1 (en) 1996-07-26 2002-11-12 Wyeth Oral contraceptive
US5888543A (en) * 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
EP2305267A3 (en) 1999-08-31 2011-08-17 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
US6787531B1 (en) 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
EP2044941A1 (en) 1999-08-31 2009-04-08 Bayer Schering Pharma AG Multiple-phase formulation of drospirenone and estradiol as a contraceptive
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US7989436B2 (en) * 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US20040176336A1 (en) * 2000-03-21 2004-09-09 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20050113351A1 (en) * 2000-03-21 2005-05-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
JP2006522833A (ja) * 2003-04-11 2006-10-05 バー・ラボラトリーズ，インコーポレイテッド エストロゲンおよびプロゲスチンの投与法
WO2005092441A2 (en) * 2004-03-19 2005-10-06 Warner Chilcott Company, Inc. Extended cycle multiphasic oral contraceptive method
DE102004019743B4 (de) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
CN101489563A (zh) 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 用于避孕和预防先天性畸形风险的药物制剂
EP1930010A1 (de) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
WO2009100871A2 (en) * 2008-02-13 2009-08-20 Bayer Schering Pharma Aktiengesellschaft Drug delivery system with stabilising effect
CN101945646A (zh) * 2008-02-13 2011-01-12 拜耳先灵医药股份有限公司 含雌二醇的药物递送系统
UY32836A (es) 2009-08-12 2011-03-31 Bayer Schering Pharma Ag Partículas estabilizadas que comprenden 5-metil-(6s)-tetrahidrofolato

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2365103C3 (de) * 1973-12-21 1980-08-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen V erwendung von Hormonen zur Kontrazeption
DE2431704A1 (de) * 1974-07-02 1976-01-22 Asche Ag Stufenkombinationspraeparate per kontrazeption
NL8001593A (nl) * 1980-03-18 1981-10-16 Akzo Nv Meerfasisch combinatiepreparaat voor orale anticonceptie.
DE3040978A1 (de) * 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
US4544554A (en) * 1983-09-26 1985-10-01 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
DE3341638A1 (de) * 1983-11-17 1984-05-03 Hermann Dr.rer.nat. 8000 München Heßlinger Dreiphasen-praeparat zur empfaengnisverhuetung aus ethinyloestradiol und lynestrenol

Also Published As

Publication number Publication date
SG72588G (en) 1989-05-26
JPH0569810B2 (el) 1993-10-01
CY1464A (en) 1989-07-21
NO845194L (no) 1985-06-24
DE3347125A1 (de) 1985-07-11
EP0148724A1 (de) 1985-07-17
FI83288C (fi) 1991-06-25
NO166756B (no) 1991-05-27
AU560487B2 (en) 1987-04-09
MY101778A (en) 1992-01-17
CA1252047A (en) 1989-04-04
ZA8410015B (en) 1985-08-28
DK623684A (da) 1985-06-23
JPS60169419A (ja) 1985-09-02
EP0148724B1 (de) 1988-06-01
HK12289A (en) 1989-02-17
ATE34665T1 (de) 1988-06-15
AU3701584A (en) 1985-07-04
FI83288B (fi) 1991-03-15
IL73889A0 (en) 1985-03-31
IL73889A (en) 1988-05-31
FI845065L (fi) 1985-06-23
PH23373A (en) 1989-07-14
NO166756C (no) 1991-09-04
DK163209B (da) 1992-02-10
FI845065A0 (fi) 1984-12-20
DK623684D0 (da) 1984-12-21
NZ210626A (en) 1988-02-29
US4621079A (en) 1986-11-04
DE3471589D1 (en) 1988-07-07

Similar Documents

Publication Publication Date Title
DK163209C (da) To- eller tretrinskombinationspraeparat til oral kontraception
AU8346082A (en) Methods and compositions for intravaginal contraception
GB2021123B (en) Surgical cements
IL72067A (en) 1-alkyl-androsta-1,4-diene-3,17-diones,processes for their preparation and pharmaceutical compositions containing the same
DE3471588D1 (en) Prostaglandins and antigestagens for the onset of labour or for the interruption of pregnancy
GB8812928D0 (en) Contraceptive methods & compositions
IL58778A0 (en) Preparation of steroids of the pregnane series
DE3263381D1 (en) Process for the preparation of methyl tert-butyl ether and ethyl tert-butyl ether
DE2967070D1 (en) 11,17-substituted pregnanes, their preparation and application for the preparation of pharmaceutical compositions
DE3261485D1 (en) Phenylpyrazole compounds useful as anti-inflammatory agents and preparation thereof
IL63022A (en) Nonapeptide having gonadoliberine activity,its preparation and compositions containing it
MX9300676A (es) Procedimiento para la preparacion de dienos esteroidales subtituidos.
DE3160507D1 (en) Process for the preparation of 3,20-dioxo-pregn-4-ene and/or 3,20-dioxo-pregna-1,4-diene
AU556482B2 (en) Castration and contraception
GB8625788D0 (en) Contraceptive methods & compositions
UA26246C2 (uk) Коhтрацептивhий комбіhоваhий препарат
GB8812814D0 (en) Contraceptive methods & compositions
GR1001395B (el) Συν?έσεις και μέ?οδοι προς πραγματοποίηση αντισύλληψης.
AR243200A1 (es) Procedimiento para la elaboracion de compuestos de 9alfa,21-dihalogeno-11 beta-hidroxi-17 alfa-alcanoiloxi-6alfa-fluor-16beta-metil-pregna-1,4-dien-3,20-diona.
AU7046681A (en) Anti-inflammatory splint cream
GB8606132D0 (en) Contraceptive composition